Ohr Pharmaceutical Inc.

Available to platforms
R StocksTrader
Ohr Pharmaceutical Inc. (Ticker: OHRP) was a biotechnology company focused on developing therapies for ophthalmic diseases, including macular degeneration and other retinal conditions. Its lead product candidate, squalamine, was investigated as a treatment for wet age-related macular degeneration. Following disappointing clinical trial results, the company shifted strategies and merged with NeuBase Therapeutics in 2019, pivoting to the development of genetic medicine therapies.

Ohr Pharmaceutical Inc. - OHRP stocks live chart

Analyze price movements of Ohr Pharmaceutical Inc. online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous OHRP quotes, get all necessary information for adding Ohr Pharmaceutical Inc. to your investment portfolio.

You can invest in Ohr Pharmaceutical Inc. and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like Ohr Pharmaceutical Inc., in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of OHRP does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Ohr Pharmaceutical Inc. (OHRP).

You can trade Ohr Pharmaceutical Inc. (OHRP) on the R StocksTrader platform.

You can trade online Ohr Pharmaceutical Inc. (OHRP) on Prime, ECN, Pro, or R StocksTrader accounts.